Platelet RNA Splicing Profiles Can Distinguish IgM MGUS Patients from Healthy Individuals
Introduction Within the general population over 50 years, 3% is affected with a monoclonal gammopathy of undetermined significance (MGUS). Although MGUS generally demands no treatment, interest in treating premalignant stages to prevent progression to overt malignancies has grown. Better insight in...
Saved in:
Published in | Blood Vol. 134; no. Supplement_1; p. 3771 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
13.11.2019
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!